Pingora Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.85M Hold
1,600
– – 1.2% 21
2026
Q2
$1.92M Hold
1,600
– – 1.12% 23
2026
Q1
$1.47M Sell
1,600
-100
-6% -$101K 0.87% 28
2025
Q4
$1.83M Hold
1,700
– – 1.12% 18
2025
Q3
$1.3M Buy
1,700
+100
+6% +$74.4K 0.86% 26
2025
Q2
$1.25M Sell
1,600
-300
-16% -$233K 0.93% 26
2025
Q1
$1.57M Hold
1,900
– – 1.16% 19
2024
Q4
$1.47M Hold
1,900
– – 0.96% 21
2024
Q3
$1.68M Hold
1,900
– – 1.19% 16
2024
Q2
$1.72M Hold
1,900
– – 1.22% 14
2024
Q1
$1.48M Hold
1,900
– – 1.08% 20
2023
Q4
$1.11M Hold
1,900
– – 0.98% 24

Other funds holding LLY

Pingora Partners's LLY Position: Q3 2026 in Review

Pingora Partners held its Eli Lilly (LLY) position steady in Q3 2026 at 1,600 shares worth $1.85M. The position accounts for 1.2% of the portfolio, ranked #21.

Pingora Partners first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.92M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Pingora Partners held 1,600 shares of Eli Lilly worth $1.85M as of Q3 2026.
  • Pingora Partners left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 1.2% of Pingora Partners's portfolio in Q3 2026, its #21 holding.
  • Pingora Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Pingora Partners's Eli Lilly position peaked at $1.92M in Q2 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Pingora Partners's 13F filing for Q3 2026, filed 13 Nov 2026.